Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00004443 · ClinicalTrials.gov registry record · NA
Study of NTBC for Tyrosinemia I
A NA study, sponsored by University of Washington.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT00004443 is a NA study that has completed, run by University of Washington. The registered enrollment target is 20 participants.
The verdict
NCT00004443, a NA study, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
OBJECTIVES: I. Assess the safety and efficacy of NTBC in children with tyrosinemia I. II. Evaluate the effects of NTBC on survival, rate of neurologic crises, improvement in renal tubular damage, reduction in the need for liver transplantation, and reduction in the development of hepatocarcinoma in these patients.
Interventions
- DRUG NTBC
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 1998-10 |
| Est. Completion | 2006-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00004443
The ClinicalTrials.gov registry entry for NCT00004443 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which NTBC is the first listed.
NCT00004443 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00004443 about?
NCT00004443 is a clinical study titled "Study of NTBC for Tyrosinemia I". OBJECTIVES: I. Assess the safety and efficacy of NTBC in children with tyrosinemia I. II. Evaluate the effects of NTBC on survival, rate of neurologic crises, improvement in renal tubular damage, reduction in the need for liver transplantation, and reduction in the development of hepatocarcinoma in...
What is the current status of trial NCT00004443?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 1998-10. Estimated completion is 2006-09.
What interventions are being tested in trial NCT00004443?
The interventions under investigation include: NTBC (DRUG).
Who is sponsoring clinical trial NCT00004443?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.